436 related articles for article (PubMed ID: 17295832)
1. Prostate cancer following testosterone replacement in Klinefelter syndrome.
Bydder SA; Joseph DJ; Weinstein S; Stuckey BG
ANZ J Surg; 2007; 77(1-2):93-4. PubMed ID: 17295832
[TBL] [Abstract][Full Text] [Related]
2. Prostatic complications of testosterone replacement therapy.
Jackson JA; Waxman J; Spiekerman AM
Arch Intern Med; 1989 Oct; 149(10):2365-6. PubMed ID: 2679476
[TBL] [Abstract][Full Text] [Related]
3. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
Coward RM; Simhan J; Carson CC
BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer in a hypogonadal male receiving androgen supplementation.
Ferri M; Norman RW
Can J Urol; 2000 Jun; 7(3):1055-6. PubMed ID: 11118282
[TBL] [Abstract][Full Text] [Related]
5. [Safety of long-term replacement hormonal therapy in patients with erectile dysfunction and androgen deficiency].
Morgunov LIu; Vertkin AL; Pushkar' DIu
Urologiia; 2007; (5):49-51. PubMed ID: 18254226
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer in Klinefelter syndrome during hormonal replacement therapy.
Hwang JJ; Dharmawardana PG; Uchio EM; Wynberg J; Phillips JL
Urology; 2003 Nov; 62(5):941. PubMed ID: 14624928
[TBL] [Abstract][Full Text] [Related]
7. The current status of therapy for symptomatic late-onset hypogonadism with transdermal testosterone gel.
Ebert T; Jockenhövel F; Morales A; Shabsigh R
Eur Urol; 2005 Feb; 47(2):137-46. PubMed ID: 15661407
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the impact of androgen deprivation therapy on sildenafil citrate response following radiation therapy for prostate cancer.
Teloken PE; Ohebshalom M; Mohideen N; Mulhall JP
J Urol; 2007 Dec; 178(6):2521-5. PubMed ID: 17937948
[TBL] [Abstract][Full Text] [Related]
9. Androgen deficiency in the etiology and treatment of erectile dysfunction.
Gore JL; Swerdloff RS; Rajfer J
Urol Clin North Am; 2005 Nov; 32(4):457-68, vi-vii. PubMed ID: 16291037
[TBL] [Abstract][Full Text] [Related]
10. Prostate volume and growth during testosterone replacement therapy is related to visceral obesity in Klinefelter syndrome.
Selice R; Caretta N; Di Mambro A; Torino M; Palego P; Ferlin A; Foresta C
Eur J Endocrinol; 2013 Dec; 169(6):743-9. PubMed ID: 24001894
[TBL] [Abstract][Full Text] [Related]
11. Testosterone replacement therapy for late onset hypogonadism: what is the risk of inducing prostate cancer?
Gould DC; Kirby RS
Prostate Cancer Prostatic Dis; 2006; 9(1):14-8. PubMed ID: 16264770
[TBL] [Abstract][Full Text] [Related]
12. The role of testosterone replacement therapy following radical prostatectomy.
Khera M; Lipshultz LI
Urol Clin North Am; 2007 Nov; 34(4):549-53, vi. PubMed ID: 17983894
[TBL] [Abstract][Full Text] [Related]
13. Effect of testosterone replacement therapy on serum PSA in patients with Klinefelter syndrome.
Shibasaki T; Sasagawa I; Suzuki Y; Yazawa H; Ichiyanagi O; Matsuki S; Miura M; Nakada T
Arch Androl; 2001; 47(3):173-6. PubMed ID: 11695839
[TBL] [Abstract][Full Text] [Related]
14. Testosterone and erectile physiology.
Guay AT
Aging Male; 2006 Dec; 9(4):201-6. PubMed ID: 17178555
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer after exogenous testosterone replacement therapy in a patient with pituitary insufficiency.
Halland A; Jønler M; Pedersen KV
Scand J Urol Nephrol; 2005; 39(1):87-8. PubMed ID: 15764279
[TBL] [Abstract][Full Text] [Related]
16. The relationship between hypogonadism and erectile dysfunction.
Hwang TI; Lin YC
Int J Impot Res; 2008; 20(3):231-5. PubMed ID: 18305486
[TBL] [Abstract][Full Text] [Related]
17. Testosterone and ageing: what have we learned since the Institute of Medicine report and what lies ahead?
Miner MM; Seftel AD
Int J Clin Pract; 2007 Apr; 61(4):622-32. PubMed ID: 17343664
[TBL] [Abstract][Full Text] [Related]
18. Clinical practice experience with testosterone treatment in men with testosterone deficiency syndrome.
McLaren D; Siemens DR; Izard J; Black A; Morales A
BJU Int; 2008 Nov; 102(9):1142-6. PubMed ID: 18540933
[TBL] [Abstract][Full Text] [Related]
19. Should testosterone replacement be offered to hypogonadal men treated previously for prostatic carcinoma?
Landau D; Tsakok T; Aylwin S; Hughes S
Clin Endocrinol (Oxf); 2012 Feb; 76(2):179-81. PubMed ID: 21951017
[TBL] [Abstract][Full Text] [Related]
20. Testosterone administration to men with testosterone deficiency syndrome after external beam radiotherapy for localized prostate cancer: preliminary observations.
Morales A; Black AM; Emerson LE
BJU Int; 2009 Jan; 103(1):62-4. PubMed ID: 18671790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
